Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 5.53 INR
Change Today +0.26 / 4.93%
Volume 3.4K
BFC On Other Exchanges
Symbol
Exchange
Natl India
As of 6:00 AM 07/28/15 All times are local (Market data is delayed by at least 15 minutes).

biofil chemicals & pharms (BFC) Snapshot

Open
5.53
Previous Close
5.27
Day High
5.53
Day Low
5.53
52 Week High
07/28/15 - 5.53
52 Week Low
12/23/14 - 1.67
Market Cap
90.0M
Average Volume 10 Days
3.3K
EPS TTM
0.36
Shares Outstanding
16.3M
EX-Date
01/1/96
P/E TM
15.4x
Dividend
--
Dividend Yield
--
Current Stock Chart for BIOFIL CHEMICALS & PHARMS (BFC)

Related News

No related news articles were found.

biofil chemicals & pharms (BFC) Related Businessweek News

No Related Businessweek News Found

biofil chemicals & pharms (BFC) Details

Biofil Chemicals & Pharmaceuticals Limited engages in the pharmaceutical, chemicals, and plastic businesses in India. It offers basic drugs and chemicals, such as sodium chloride, potassium chloride, sodium citrate, diethyl carbamazine citrate, ferrous sulphate, dried ferrous sulphate, ferrus fumerate, micro crystalline cellulose, and dicyclomine hydrochloride; and plastic dippers and caps. The company was founded in 1985 and is based in Indore, India.

Founded in 1985

biofil chemicals & pharms (BFC) Top Compensated Officers

Executive
Total Annual Compensation: 432.0K
Compensation as of Fiscal Year 2014.

biofil chemicals & pharms (BFC) Key Developments

Biofil Chemicals & Pharmaceuticals Ltd. Announces Audited Earnings Results for the Fourth Quarter and Year Ended March 31, 2015

Biofil Chemicals & Pharmaceuticals Ltd. announced audited earnings results for the fourth quarter and year ended March 31, 2015. For the quarter, the company reported net sales/income from operations (net of excise duty) of INR 26.342 million compared to INR 11.324 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 3.048 million compared to INR 7.349 million reported a year ago. Profit from ordinary activities before tax was INR 5.058 million compared to INR 7.121 million reported a year ago. Net profit was INR 3.657 million or INR 0.225 per basic and diluted share before and after extraordinary items compared to net profit of INR 5.881 million or INR 0.361 per basic and diluted share before and after extraordinary items reported a year ago. For the full year, the company reported net sales/income from operations (net of excise duty) of INR 45.645 million compared to INR 48.888 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 4.830 million compared to INR 7.444 million reported a year ago. Profit from ordinary activities before tax was INR 7.273 million compared to INR 6.406 million reported a year ago. Net profit after tax was INR 5.872 million or INR 0.361 per basic and diluted share before and after extraordinary items compared to net profit of INR 5.166 million or INR 0.317 per basic and diluted share before and after extraordinary items reported a year ago.

Biofil Chemicals & Pharmaceuticals Ltd. to Report Q4, 2015 Results on May 30, 2015

Biofil Chemicals & Pharmaceuticals Ltd. announced that they will report Q4, 2015 results on May 30, 2015

Biofil Chemicals & Pharmaceuticals Ltd., Board Meeting, May 30, 2015

Biofil Chemicals & Pharmaceuticals Ltd., Board Meeting, May 30, 2015. Agenda: To consider audited financial results of the company for the quarter as well as financial year ended on March 31, 2015.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BFC:IN 5.53 INR +0.26

BFC Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BFC.
View Industry Companies
 

Industry Analysis

BFC

Industry Average

Valuation BFC Industry Range
Price/Earnings 7.8x
Price/Sales 1.0x
Price/Book 0.5x
Price/Cash Flow 5.5x
TEV/Sales 0.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOFIL CHEMICALS & PHARMS, please visit www.biofilgroup.net. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.